Compare Conagra Brands Inc (CAG) vs Canopy Growth Corp (CGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Conagra Brands Inc vs Canopy Growth Corp — how do they compare? Conagra Brands Inc trades at $15.36 (market cap $7.18B), while Canopy Growth Corp trades at $1.02 (market cap $430.60M). The key difference: Conagra Brands Inc is far larger — about 16.7× Canopy Growth Corp's market cap, and Conagra Brands Inc pays a 8.19% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CAG | CGC | |
|---|---|---|
Market Cap | $7.18B | $430.60M |
Sector | Consumer Staples | Health |
52-Week High | $20.02 | $1.92 |
52-Week Low | $12.58 | $0.86 |
Enterprise Value | $14.23B | $388.01M |
Dividend Yield | 8.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Conagra Brands (CAG) trades at $15.385, up 2.94% today, with a bullish technical signal and mixed earnings history. The stock shows attractive valuation with a P/E of 10.06 and P/S of 0.64, but faces challenges including a net income margin of -16.99% for 2026 and a recent 50% dividend cut. Recent news highlights leadership changes and strategic shifts under new CEO John Brase to streamline operations and address margin pressures amid inflationary headwinds.
The outlook is cautious; while low valuation provides downside support, persistent sales declines and margin compression pose risks. Analyst consensus is mixed with a $13.67 price target below current levels, indicating skepticism about near-term recovery. Investors should weigh the potential for a turnaround against ongoing operational and macroeconomic challenges.
CGC trades at $1.01, up 1.0% in the last session, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q1 fiscal 2027 revenue growth of 13% year-over-year, beating estimates, yet continues to post net losses. Recent news highlights expansion in European medical cannabis markets and cost-cutting efforts, while analyst consensus is mixed with 33% buy ratings.
Outlook remains speculative with high execution risk; improving cash flow trends and potential U.S. rescheduling offer upside, but persistent negative margins and debt concerns weigh on equity value. Investors should weigh growth prospects against profitability challenges in the volatile cannabis sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Conagra Brands Inc
Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of revenue and profits). It has a significant presence in the freezer aisle, with brands such as Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Other popular brands include Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. While the majority of revenue is sold into the U.S. retail channel, 9% of fiscal 2022 sales were to the food-service channel, down from 11% in fiscal 2019 due to the pandemic.
Read more on CAG →About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →
